A drug is developed to specifically inhibit receptor serine/threonine kinases. What would be the expected effect on the TGF-beta signaling pathway?

• A. Inhibition of the pathway due to lack of receptor activation.
• B. No effect on the pathway.
• C. Increased activation of the pathway.
• D. Complete degradation of the receptor.

Answer: (A)